Patent

CHA Medical Group has been studying various fields of cytotherapy using stem cells (e.g. embryo, adult somatic stem cell, and cell dedifferentiation) and constructing a patent portfolio in order to secure its rights in cell separation, differentiation, culture, and treatments. In addition to cytotherapy, CHA Medical Group has been pursuing intellectual property rights world-wide for developments in other areas such as synthetic drugs, modified drugs, vaccines and drug screening.

Cell therapy

Embryonic-derived stem cell

Apply embryonic-derived stem cells for various
indications by differentiating them to retinal
pigment epithelium (RPE)
Differentiation to various stem cells including
embryonic-derived stem cells, culturing methods,
and pharmaceutical composite materials

Placenta-derived stem cell

Separation, culture, and pharmaceutical usage of
placenta-derived mesenchymal stem cells for
various indications

Umbilical cord-derived stem cell

Separation, culture, and pharmaceutical usage of
umbilical cord-derived stem cells for various
indications

Cord blood

Agents including cord blood or cord
blood-derived stem cells and its pharmaceutical
usage for various indications

Fat-derived stem cell

Separation, culture, and pharmaceutical usage of
fat-derived stem cells for various indications

Testis-derived stem cell

Testis-derived pluripotent stem cell
manufacturing methods and its pharmaceutical
usage for various indications

Induced pluripotent stem cell (iPSC)

Induced pluripotent stem cell methods,
associated pharmaceutical composite materials,
and screening methods

Immunocyte

Natural killer cell, dendritic cell, or T lymphocyte
manufacturing methods and its pharmaceutical
usage for various indications including cancer

Stem cell bank and platform
technology

Stem cell bank

The stem cell bank operation system and its usage

Platform technology

Drug screening using stem cells, customized diet
suggestion system, and screening system for
embryonic stem cell culture

Oral thin film (OTF)

Oral films for delivering active ingredients into the
body

Biomaterials

Filler Medical biomaterials and fillers

Anti-intestinal adhesive film
Anti-intestinal adhesive films including special
active ingredients

Biomarkers, device, and kit

Biomarkers of various diseases such as
miscarriage, ovarian syndrome, cerebral palsy,
brain damage, diagnostic devices, and kits using
biomarkers

Cosmetics

Culture fluid originated from various tissues or
cells, such as placenta-derived or stem
cell-derived ingredients, and cosmetics composite
materials including active ingredients

Vaccine

Manufacturing methods of HBV vaccine and mass
production of vaccine adjuvant and HBV vaccine

Cell extract

Centrifugation bags, separation devices, etc. for
extracting SVF (Stromal Vascular Fraction) or stem
cells

scroll to top button